Relapsed/Refractory Acute Leukemia

specific

An acute leukemia that does not respond to treatment.

Centers

Active Trials

—

Cancer Funding

Top Centers for Relapsed/Refractory Acute Leukemia(13)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Active Trials	Cancer Funding	Score
1	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive	—	—	53.8
2	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive	—	—	53.8
3	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive	—	—	53.8
4	Siteman Cancer CenterSt. Louis, MO NCI Comprehensive	—	—	53.8
5	Duke Cancer InstituteDurham, NC NCI Comprehensive	—	—	53.8
6	Winship Cancer InstituteAtlanta, GA NCI Comprehensive	—	—	53.8
7	Comprehensive Cancer Center St. Jude Children’s Research HospitalMemphis, TN NCI Comprehensive	—	—	53.8
8	University of Colorado Cancer CenterAurora, CO NCI Comprehensive	—	—	53.8
9	University of Illinois Cancer CenterChicago, IL	—	—	53.8
10	Boston University Cancer CenterBoston, MA	—	—	53.8
11	Cancer Center at IllinoisUrbana, IL	—	—	53.8
12	University of Cincinnati Cancer CenterCincinnati, OH	—	—	53.8
13	Louisiana Cancer Research CenterNew Orleans, LA	—	—	53.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →